Home Cart 0 Sign in  

[ CAS No. 1187595-84-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1187595-84-1
Chemical Structure| 1187595-84-1
Structure of 1187595-84-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1187595-84-1 ]

Related Doc. of [ 1187595-84-1 ]

Alternatived Products of [ 1187595-84-1 ]

Product Details of [ 1187595-84-1 ]

CAS No. :1187595-84-1 MDL No. :MFCD25976707
Formula : C16H20N7O6PS Boiling Point : -
Linear Structure Formula :- InChI Key :FBPOWTFFUBBKBB-UHFFFAOYSA-N
M.W : 469.41 Pubchem ID :44231848
Synonyms :
INCB028050 phosphate;LY3009104 phosphate
Chemical Name :2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile phosphate

Calculated chemistry of [ 1187595-84-1 ]

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 14
Fraction Csp3 : 0.38
Num. rotatable bonds : 5
Num. H-bond acceptors : 11.0
Num. H-bond donors : 4.0
Molar Refractivity : 112.77
TPSA : 216.51 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -10.97 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.32
Log Po/w (XLOGP3) : -2.55
Log Po/w (WLOGP) : 0.87
Log Po/w (MLOGP) : -2.07
Log Po/w (SILICOS-IT) : 0.61
Consensus Log Po/w : -0.57

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.15
Solubility : 33.4 mg/ml ; 0.0711 mol/l
Class : Very soluble
Log S (Ali) : -1.45
Solubility : 16.6 mg/ml ; 0.0353 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -4.38
Solubility : 0.0197 mg/ml ; 0.000042 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.43

Safety of [ 1187595-84-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1187595-84-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1187595-84-1 ]
  • Downstream synthetic route of [ 1187595-84-1 ]

[ 1187595-84-1 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 1187594-09-7 ]
  • [ 1187595-84-1 ]
YieldReaction ConditionsOperation in experiment
99.2% With phosphoric acid In methanol; water; acetonitrile at 68℃; for 1 h; Baricitinib (0.30 g; 0.8 nimol) was dissolved in acetonitrile (7 ml) under boiling and during30 minutes, a solution of phosphoric acid (0.20 g; 2.1 equivalents; 85percent cone. in water) inmethanol (1.2 ml) was added by dripping. The obtained suspension was stirred for 1 hour at the temperature of 68°C, then it was slowly cooled down to the laboratory temperature and stirred overnight. The precipitate was filtered off and dried at 35°C and 200 mbar for 18h. Baricitinib phosphate of form C was obtained as white powder (376 mg; 99.2percent). Stoichiometry 1:1.14.
93% With phosphoric acid In ethanol; acetonitrile at 70℃; for 2 h; To a solution of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile (7, 204 g, 550 mmol) in acetonitrile (5.1 L) and ethanol (1.6 L) was added a solution of phosphoric acid (67.4 g, 688 mmol, 1.25 equiv) in ethanol (800 mL) slowly over 30 min at 70° C.
The resulting reaction mixture was stirred at 70° C. for 2 h before being gradually cooled to room temperature with stirring for overnight.
The solids were collected by filtration, washed with acetonitrile (160 mL) and dried in vacuum oven at 45° C. for 6 h to afford 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile phosphoric acid salt (240 g, 258.2 g theoretical, 93percent yield) as a white solid.
Reference: [1] Patent: WO2018/113801, 2018, A1, . Location in patent: Page/Page column 17; 18; 19; 20
[2] Patent: US2009/233903, 2009, A1, . Location in patent: Page/Page column 59; 60; 64-65
Same Skeleton Products
Historical Records

Similar Product of
[ 1187595-84-1 ]

Chemical Structure| 1187594-09-7

A102707[ 1187594-09-7 ]

2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile

Reason: Free-salt